Biotech

All Articles

Analysts examine Avidity's DMD win, uncovering distinctions in data

.Avidity Biosciences satisfied entrepreneurs with phase 1/2 data in Duchenne muscular dystrophy (DMD...

Actinogen's cortisol blocker fails stage 2 clinical depression study

.Actinogen Medical's cortisol blocker has actually missed the major endpoint of a phase 2 study in d...

Bivictrix decides going exclusive only method to take ADC into medical clinic

.Antibody-drug conjugates (ADCs) have been at the center of a lot of a billion-dollar biobuck licens...

TPG leadings up funds to $580M for investments around lifestyle sciences

.Resource supervisor TPG, which has actually supported biotechs like Sionna Therapeutics and also Sa...

Merck stops period 3 TIGIT test in bronchi cancer for futility

.Merck &amp Co.'s TIGIT course has actually endured one more misfortune. Months after shuttering a p...

After a challenging year, Exscientia folds up into Recursion

.After a year defined by pipeline hairstyles, the shift of its own chief executive officer and also ...

Cullinan, after $25M offer, return bispecific to Port

.Cullinan Therapeutics was actually excited sufficient with Harbour BioMed's bispecific immune syste...

A nearer check out Tough Biotech's Ferocious 15

.In this week's episode of "The Top Line," our company are actually diving right into Fierce Biotech...

Lilly experiences stage 2 breakdown of tau-targeting med

.The confetti is still flying from Eli Lilly's gathering commemorating the commendation of Alzheimer...

Biogen CMO Maha Radhakrishnan signs up with Sofinnova-- Chutes &amp Ladders

.Accept to recently's Chutes &amp Ladders, our summary of significant leadership hirings, firings an...